Last $32.50 USD
Change Today +1.10 / 3.50%
Volume 966.4K
THOR On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

thoratec corp (THOR) Snapshot

Open
$31.11
Previous Close
$31.40
Day High
$32.91
Day Low
$31.11
52 Week High
10/31/13 - $43.58
52 Week Low
05/7/14 - $30.01
Market Cap
1.8B
Average Volume 10 Days
493.3K
EPS TTM
$1.37
Shares Outstanding
56.8M
EX-Date
--
P/E TM
23.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for THORATEC CORP (THOR)

thoratec corp (THOR) Related Businessweek News

No Related Businessweek News Found

thoratec corp (THOR) Details

Thoratec Corporation develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart failure patients. The company’s primary product lines include ventricular assist devices, such as HeartMate II, an implantable left ventricular assist device consisting of a rotary blood pump to provide intermediate and long-term mechanical circulatory support (MCS); and HeartMate XVE, an implantable and pulsatile left ventricular assist device for intermediate and longer-term MCS. Its ventricular assist devices also comprise CentriMag, an extracorporeal full-flow acute surgical support platform that offers support up to 30 days for cardiac and respiratory failure; and PediMag and PediVAS extracorporeal full-flow acute surgical support platforms designed to provide acute surgical support to pediatric patients. In addition, the company provides Paracorporeal Ventricular Assist Device, an external pulsatile ventricular assist device, which provides left, right, and biventricular MCS approved for bridge-to-transplantation (BTT), including home discharge and post-cardiotomy myocardial recovery; and Implantable Ventricular Assist Device, an implantable and pulsatile ventricular assist device designed to provide left, right, and biventricular MCS approved for BTT comprising home discharge and post-cardiotomy myocardial recovery. It sells its products through direct sales force and distributors in the United States and internationally. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.

951 Employees
Last Reported Date: 02/18/14
Founded in 1976

thoratec corp (THOR) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $570.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $302.3K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $338.3K
Compensation as of Fiscal Year 2013.

thoratec corp (THOR) Key Developments

Thoratec Corporation Announces First HeartMate III(TM) Human Implant and Start of CE Mark Trial

Thoratec Corporation announced that its CE Mark Clinical Trial for HeartMate III(TM) commenced with the first patient implanted with this new device. HeartMate III is a centrifugal-flow chronic left ventricular assist system. The fully magnetically levitated technology foundation of HeartMate III is designed to lower adverse event rates through improved hemocompatibility while enhancing ease of surgical placement through a compact size.

Thoratec Corp. Presents at William Blair & Company's 34th Annual Growth Stock Conference, Jun-11-2014 04:40 PM

Thoratec Corp. Presents at William Blair & Company's 34th Annual Growth Stock Conference, Jun-11-2014 04:40 PM. Venue: Four Seasons Hotel, 120 East Delaware Place, Chicago, Illinois, United States. Speakers: Taylor C. Harris, Chief Financial Officer, Principal Accounting Officer and Vice President.

Thoratec Corp. Announces Executive Appointments; Approves Amendment to Restated Articles of Incorporation

On May 22, 2014, Thoratec Corp. hired Vasant Padmanabhan, PhD, as Senior Vice President, Technical Operations. Dr. Padmanabhan, will join the company in early June. Dr. Padmanabhan was Vice President, Product Development, Implantable Defibrillator Business at Medtronic Inc. from May 2012 until May 2014. The company at its AGM approved Martha H. Marsh as director. The company at its annual meeting of shareholders held on May 21, 2014 approved an amendment to the company’s restated articles of incorporation concerning limitation of director liability and indemnification of directors, officers and employees.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THOR:US $32.50 USD +1.10

THOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cyberonics Inc $59.47 USD -1.04
Merit Medical Systems Inc $12.84 USD +0.05
NuVasive Inc $37.38 USD -0.83
Tornier NV $20.73 USD -0.87
Wright Medical Group Inc $30.82 USD -0.63
View Industry Companies
 

Industry Analysis

THOR

Industry Average

Valuation THOR Industry Range
Price/Earnings 24.9x
Price/Sales 3.5x
Price/Book 2.6x
Price/Cash Flow 24.3x
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THORATEC CORP, please visit www.thoratec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.